日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CXCR4-antagonistic peptide-decorated lipid nanoparticles for co- delivery of AML1-ETO siRNA to enhance chemotherapy in refractory AML

CXCR4拮抗肽修饰的脂质纳米颗粒用于共递送AML1-ETO siRNA以增强难治性AML的化疗效果

Peng, Xuelu; Gu, Runxia; Wang, Tao; Jiang, Chuanmei; Xing, Haiyan; Meng, Jie; Wen, Tao; Liu, Jian; Wang, Jianxiang; Xu, Haiyan

Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia

FLT3-ITD 和获得性 13q 单亲二体性的克隆结构决定了急性髓系白血病的预后异质性和治疗脆弱性。

Lai, Anli; Liu, Wenbing; Mei, Yihan; Zhang, Qimin; Zhang, Junping; Tang, Kejing; Rao, Qing; Gu, Runxia; Feng, Sizhou; Wang, Ying; Wang, Min; Wei, Hui; Mi, Yingchang; Qiu, Shaowei; Wang, Jianxiang

Inaticabtagene autoleucel in adult relapsed or refractory B-cell acute lymphoblastic leukemia

Inaticabtagene autoleucel 治疗成人复发或难治性 B 细胞急性淋巴细胞白血病

Wang, Ying; Lv, Lulu; Song, Yongping; Wei, Xudong; Zhou, Hongsheng; Liu, Qifa; Xu, Kailin; Yan, Dongmei; Zhang, Cheng; Liu, Shuangyou; Jin, Jie; Mei, Heng; Niu, Ting; Liang, Aibin; Gu, Runxia; Ren, Jienan; Feng, Yi; Jin, Wei; Zhou, Yan; Deng, Yiping; Wang, Jianxiang

Progression significance for low-level aberrant B-lymphoblasts in chronic myeloid leukaemia patients

慢性粒细胞白血病患者中低水平异常B淋巴母细胞的进展意义

Wang, Haoren; Wang, Huijun; Li, Yuanyuan; Zheng, Bin; Fang, Qiuyun; Li, Yan; Liu, Yuntao; Gu, Runxia; Wang, Ying; Mi, Yingchang; Liu, Bingcheng; Wei, Hui; Wang, Jianxiang

The critical role of DNA damage-inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation

DNA损伤诱导转录物4(DDIT4)在白血病细胞干性特征和白血病发生中的关键作用

Li, Yishuang; Cao, Zhijie; Xing, Haiyan; Xue, Zhenya; Liu, Wenbing; Chen, Jiayuan; Mei, Yihan; Gu, Runxia; Wei, Hui; Qiu, Shaowei; Wang, Min; Rao, Qing; Wang, Jianxiang

The Clinical and Molecular Characterization of Distinct Subtypes in Adult T Cell Acute Lymphoblastic Leukemia

成人T细胞急性淋巴细胞白血病不同亚型的临床和分子特征

Yu, Heye; Liu, Wenbing; Zhang, Junping; Xie, Leling; Lai, Anli; Tian, Zheng; Tang, Kejing; Xing, Haiyan; Wang, Ying; Wei, Hui; Rao, Qing; Gu, Runxia; Wang, Min; Wang, Huijun; Wang, Jianxiang; Qiu, Shaowei

Prognostic impact of co-mutations in adults with IDH1/2-mutated acute myeloid leukemia

IDH1/2突变型急性髓系白血病成人患者共突变的预后影响

Lai, Anli; Liu, Wenbing; Zhou, Chunlin; Li, Yan; Wei, Shuning; Liu, Kaiqi; Gong, Benfa; Gong, Xiaoyuan; Liu, Yuntao; Zhang, Guangji; Zhang, Junping; Gu, Runxia; Qiu, Shaowei; Liu, Bingcheng; Wang, Ying; Wei, Hui; Mi, Yingchang; Wang, Jianxiang

Multiomic analysis identifies a high-risk subgroup that predicts poor prognosis in t(8;21) acute myeloid leukemia

多组学分析识别出一个高风险亚组,该亚组可预测t(8;21)急性髓系白血病的不良预后。

Liu, Yu; Liu, Wenbing; Lai, Anli; Mei, Yihan; Wang, Ying; Wei, Hui; Rao, Qing; Gu, Runxia; Mi, Yingchang; Wang, Min; Wang, Jianxiang; Qiu, Shaowei

A pediatric-inspired regimen for adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a prospective study from China

一项针对费城染色体阴性急性淋巴细胞白血病青少年及成人患者的儿科治疗方案:来自中国的前瞻性研究

Gong, Xiaoyuan; Fang, Qiuyun; Gu, Runxia; Qiu, Shaowei; Liu, Kaiqi; Lin, Dong; Zhou, Chunlin; Zhang, Guangji; Gong, Benfa; Liu, Yuntao; Li, Yan; Liu, Bingcheng; Wang, Ying; Wei, Hui; Mi, Yingchang; Wang, Jianxiang

A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells.

采用双靶点策略,利用抗IL10R CAR-T细胞释放抗CD33双特异性抗体,增强对急性髓系白血病细胞的杀伤作用。

Yan Zhifeng, Gu Runxia, Ma Haotian, Chen Nianci, Zhang Ting, Xu Yingxi, Qiu Shaowei, Xing Haiyan, Tang Kejing, Tian Zheng, Rao Qing, Wang Min, Wang Jianxiang